Donna S. Shewach

6.3k citations

98 papers · 5.0k indexed · 1 hit paper · h-index 38

Molecular Biology top 2%
Oncology top 1%
Pulmonary and Respiratory Medicine top 2%
Epidemiology top 5%
Cancer Research top 2%

Co-authors: Theodore S. Lawrence Larry W. Hertel Michael M. Im Robert D. Kuchta Tina M. Hahn Leo J. Ostruszka Beverly S. Mitchell Paul D. Boucher
Topics: Biochemical and Molecular Research (28 papers)DNA Repair Mechanisms (27 papers)Virus-based gene therapy research (15 papers)
Cited by: Oncology Physiology Cancer Research
Journals: Cell Chemical Reviews Proceedings of the National Academy of Sciences
Partner nations: United States Russia Israel

In The Last Decade

Donna S. Shewach

98 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nucleotide Deficiency Promotes Genomic Instability in Early Stages of Cancer Development

2011 635 citations Assaf C. Bester, Maayan Roniger et al. Cell profile →

Peers

Countries citing papers authored by Donna S. Shewach

Since Specialization

Citations

This map shows the geographic impact of Donna S. Shewach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna S. Shewach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna S. Shewach more than expected).

Fields of papers citing papers by Donna S. Shewach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna S. Shewach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna S. Shewach. The network helps show where Donna S. Shewach may publish in the future.

Co-authorship network of co-authors of Donna S. Shewach

This figure shows the co-authorship network connecting the top 25 collaborators of Donna S. Shewach. A scholar is included among the top collaborators of Donna S. Shewach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna S. Shewach. Donna S. Shewach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Late DNA Damage Mediated by Homologous Recombination Repair Results in Radiosensitization with Gemcitabine 2016 ·Radiation Research ·Michael M. Im,(unknown),Jeffrey J. Ackroyd,(unknown),(unknown),Donna S. Shewach	5
2	Drug Metabolism and Homologous Recombination Repair in Radiosensitization with Gemcitabine 2015 ·Radiation Research ·Michael M. Im,(unknown),Jeffrey J. Ackroyd,Donna S. Shewach	7
3	Nucleotide Deficiency Promotes Genomic Instability in Early Stages of Cancer Developmentbreakdown → 2011 ·Cell ·Assaf C. Bester,Maayan Roniger,Yifat S. Oren,Michael M. Im,(unknown),(unknown),Aaron Bensimon,Gideon Zamir,Donna S. Shewach,Batsheva Kerem	635
4	Unrepairable DNA double-strand breaks initiate cytotoxicity with HSV-TK/ganciclovir 2011 ·Cancer Gene Therapy ·Brendon Ladd,Jessica J. O’Konek,Leo J. Ostruszka,Donna S. Shewach	17
5	Alteration of the carbohydrate for deoxyguanosine analogs markedly changes DNA replication fidelity, cell cycle progression and cytotoxicity 2009 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Jessica J. O’Konek,Brendon Ladd,(unknown),(unknown),Paul D. Boucher,(unknown),John A. Secrist,Donna S. Shewach	2
6	MLH1 Deficiency Enhances Radiosensitization with 5-Fluorodeoxyuridine by Increasing DNA Mismatches 2008 ·Molecular Pharmacology ·(unknown),(unknown),Sudha Mannava,Mikhail A. Nikiforov,Donna S. Shewach	7
7	Activation of mismatch repair protects cells against ganciclovir cytotoxicity through decreasing errors in DNA replication 2007 ·Cancer Research ·Jessica J. O’Konek,Paul J. Rice-Boucher,Donna S. Shewach	1
8	siRNA for p53R2 inhibits increases in p53R2 expression following exposure to DNA damaging agents. 2006 ·Cancer Research ·(unknown),Donna S. Shewach	1
9	GCV phosphates are transferred between HeLa cells despite lack of bystander cytotoxicity 2005 ·Gene Therapy ·(unknown),(unknown),Paul D. Boucher,Randall J. Ruch,Donna S. Shewach	12
10	In Vitro and in Vivo Enhancement of Ganciclovir-Mediated Bystander Cytotoxicity with Gemcitabine 2005 ·Molecular Therapy ·Paul D. Boucher,Donna S. Shewach	16
11	A Phase I Dose Escalation Trial of Gemcitabine with Radiotherapy for Breast Cancer in the Treatment of Unresectable Chest Wall Recurrences 2004 ·The Breast Journal ·W. Warren Suh,Anne F. Schott,James A. Hayman,Matthew J. Schipper,Donna S. Shewach,Lori J. Pierce	11
12	Improved method to prepare RNA-free DNA from mammalian cells 1997 ·Journal of Chromatography B Biomedical Sciences and Applications ·(unknown),Donna S. Shewach	10
13	Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine 1996 ·International Journal of Radiation OncologyBiologyPhysics ·Theodore S. Lawrence,Emily Yun‐Chia Chang,Tina M. Hahn,Larry W. Hertel,Donna S. Shewach	255
14	Radiosensitizing Nucleosides 1996 ·JNCI Journal of the National Cancer Institute ·C.J. McGinn,Donna S. Shewach,Theodore S. Lawrence	121
15	Decrease in TTP pools mediated by 5-bromo-2'-deoxyuridine exposure in a human glioblastoma cell line 1992 ·Biochemical Pharmacology ·Donna S. Shewach,(unknown),William R. Mancini,William D. Ensminger	24
16	Nucleotide specificity of human deoxycytidine kinase. 1992 ·Molecular Pharmacology ·Donna S. Shewach,Kara Reynolds,Larry W. Hertel	99
17	The effects of leucovorin and dipyridamole on fluoropyrimidine-induced radiosensitization 1991 ·International Journal of Radiation OncologyBiologyPhysics ·Theodore S. Lawrence,D.K. Heimburger,Donna S. Shewach	18
18	The effect of fluorodeoxyuridine on sublethal damage repair in human colon cancer cells 1991 ·International Journal of Radiation OncologyBiologyPhysics ·D.K. Heimburger,Donna S. Shewach,Theodore S. Lawrence	26
19	Properties of Highly Purified Human T Lymphoblast (Molt-4) Deoxycytidine Kinase 1989 ·Advances in experimental medicine and biology ·N S Datta,Donna S. Shewach,Mary C. Hurley,Beverly S. Mitchell,Irving H. Fox	1
20	Relationship between ARA-ATP concentration, DNA synthetic capacity (DSC) and viability in CHO cells 1981 ·Proceedings of the American Association for Cancer Research ·Donna S. Shewach,R.B. Naso,William Plunkett	1

About Donna S. Shewach

Donna S. Shewach is a scholar working on Physiology, Molecular Biology and Oncology, having authored 98 papers that have together received 5.0k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (28 papers), DNA Repair Mechanisms (27 papers) and Virus-based gene therapy research (15 papers). The work is most often cited by research in Oncology (1.8k citations), Physiology (237 citations) and Cancer Research (690 citations). Donna S. Shewach has collaborated with scholars based in United States, Russia and Israel. Frequent co-authors include Theodore S. Lawrence, Larry W. Hertel, Michael M. Im, Robert D. Kuchta, Tina M. Hahn, Leo J. Ostruszka, Beverly S. Mitchell, Paul D. Boucher, Emily Yun‐Chia Chang and Batsheva Kerem. Their work appears in journals such as Cell, Chemical Reviews and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact